• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Personalized Brain Stimulation Improves Walking Among Parkinson's Patients

By Dennis Thompson HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 28, 2025.

MONDAY, July 28, 2025 — Parkinson’s disease can dramatically affect a patient’s ability to walk, with “Parkinson’s gait” increasing their fall risk and reducing their ability to get around.

But deep brain stimulation (DBS) custom-tailored to a patient’s brain activity and gait pattern can effectively improve walking ability, a new study says.

Tweaking a patient’s brain stimulation based on analysis of factors like step length, stride speed and arm swing successfully enhanced their overall movement, researchers report in the journal npj Parkinson’s Disease.

“This work not only deepens our understanding of how DBS affects movement but also highlights the promise of personalized neuromodulation for Parkinson’s and other neurological disorders, bringing us closer to smarter more effective neuromodulation therapies,” senior researcher Dr. Doris Wang, an associate professor of neurological surgery at the University of California-San Francisco (UCSF), said in a news release.

DBS involves an implanted device that delivers electrical current directly to different areas of the brain, giving them a kick-start. It is highly effective in treating tremors, rigidity and slow movement among Parkinson’s patients, but its impact on gait has not been as reliable, researchers said in background notes.

Parkinson's disease is a progressive movement disorder that causes people to shake, become stiff or have trouble with their balance and coordination. It occurs when the brain cells that create the hormone dopamine die or become impaired.

For the new study, researchers worked with three different Parkinson’s patients to suss out a way to improve DBS’ effectiveness in treating walking problems.

During clinic visits, the patients walked in a six-meter loop while researchers adjusted their DBS settings and recorded their brain and movement activity.

Based on these readings, the researchers developed a walking performance index (WPI) that provided a comprehensive assessment of how Parkinson’s affects a person’s movement.

The team identified also brain activity patterns linked to better walking, particularly in the globus pallidus, a part of the brain associated with a loss of muscle movement in Parkinson’s patients.

“Our results confirmed that changes in DBS settings were effectively captured by the WPI, aligning with patient and clinician evaluations during each visit,” said lead researcher Hamid Fekri Azgomi, a postdoctoral scholar under Wang at UCSF.

“This validation supports that the WPI is an effective metric for assessing and targeting gait improvements in people with Parkinson’s,” Azgomi said in a news release. “Using these techniques, we were able to predict and identify personalized DBS settings that improved the WPI.”

Future research will focus on automated systems that can capture gait patterns in real-time and feed the data into DBS programming software, using the WPI to make more accurate adjustments, researchers said.

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2025

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.